09:30 – 12:30 (180’), Orche Ⅰ&Ⅱ
13:30 – 16:30 (180’), Orche Ⅰ
14:15 – 15:15 (60’), Orche Ⅱ
15:30 – 18:00 (150’), Orche Ⅱ
This session focuses on the roles and expertise required of clinicians in MDR clinical evaluation,
examining key practical tasks such as preparing Clinical Evaluation Reports (CER) and assessing clinical evidence.

| Time | Title | Speaker |
|---|---|---|
| Clinical Research Consortium (Closed) | ||
| 13:00 - 13:05 (05’) | Opening Remarks | Lim Sanghyun Ajou University Hospital Director & Professor |
| 13:05 - 13:10 (05’) | Welcome Remarks | Kim Yura Ministry of Health and Welfare Director |
| 13:10 - 13:15 (05‘) | Special Remarks | Lee Haengshin KHIDI Executive Director |
| 13:15 - 13:25 (10‘) | Presentation of the MOU Details | KHIDI |
| 13:25 - 13:35 (10‘) | Signing and Exchange of the Agreement | |
| 13:35 - 13:45 (10‘) | Commemorative Photo Session and Closing | |
| 13:45 – 14:00 (15‘) | Coffee & break | |
| European MDR Clinical Evaluation Seminar and Panel Discussion (Public) | ||
| 14:00 - 14:40 (40‘) |
[Presentation] The Role of Physicians in Clinical Evaluation and CER Preparation * Playback of Pre‑Recorded Video |
Maja Copik TUV Rheinland Clinical Expert |
| 14:40 - 15:00 (20‘) |
[Panel Discussion] Direction for Advancing Medical Device Clinical Validation and Clinical Evaluation * 5‑Minute Presentation per Panelist |
(Moderator) Lim Sanghyun Ajou University Hospital Director & Professor |
You can click on each speaker to view their Professional Experience and Abstract.

TUV Rheinland
Clinical Expert
She is a specialist in anesthesiology and critical care medicine, practicing at a university hospital in Poland and teaching at the Medical University of Silesia. Since 2019, she has served as a Clinical Expert for TÜV Rheinland, conducting medical device clinical evaluations under the EU MDR. She has expertise in clinical evaluation, PMCF, benefit risk assessment, and the appraisal of clinical evidence.
This presentation explores the role of clinical expertise and healthcare professionals in MDR clinical evaluation. It will examine how clinicians assess a device’s intended purpose, clinical claims, comparator therapies, and clinical data. The session will cover benefit risk assessment, evidence gaps and PMCF planning, CECP and high risk device review, and provide a practical CER checklist along with key considerations for real world application.